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SUMMARY Multicentric reticulohistiocytosis is a very rare systemic 
disease that affects skin, mucosa and joints. We reported a case 
of a woman with multicentric reticulohistiocytosis who presented 
typical skin syndromes and arthralgia. Immunohistochemical 
analysis showed positive staining for S100 protein, which was 
reported negative in the majority of previously presented cases. 
Other immunohistochemical markers (CD68(+), CD1a(-), lagerin 
(-) and complete histologic and clinical picture were specific enough 
to make the definitive diagnosis of multicentric reticulohistiocytosis. 
The patient was administered prednisone just when arthritis 
appeared and we believe that this therapy protected her from the 
development of destructive arthritis. No autoimmune disease or 
internal malignancy was observed during 12-month follow up.
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INTRODUCTION
 Multicentric reticulohistiocytosis (MR) is a rare 
systemic disorder of unknown etiology, classified 
as a non-Langerhans cell histiocytosis. It mainly 
affects skin, mucosa and synovia, and usually 
causes destructive symmetric arthritis. MR often 
affects internal organs and can also coexist with 
autoimmune diseases and/or malignancy (1). 
Goltz and Laymon (2) introduced MR as a new 
nosologic entity in 1954.
 CASE REPORT
 A 30-year-old Caucasian woman was admit-
ted to the Wroclaw Department of Dermatology 
because of dark-red nodules that appeared on the 
skin of her hands. The diameters of the lesions 
were between 2 and 7 mm. The nodules were hard, 
painless and had a tendency to linear arrange-
ment like Koebner phenomenon (Fig. 1). There 
were additional small nodules localized along the 
proximal nail fold, known as a ‘coral beads’ sign. 
Moreover, there were numerous small papules 
symmetrically located on the face, in particular on 
the dorsal part of the nose. No erosions, ulcers or 
scales were observed. 
 Histology of the biopsy specimens obtained 
from the skin of the nose and hands showed very 
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similar patterns characterized by abundant infiltra-
tion of histiocytes with homogeneous copious eo-
sinophilic cytoplasm and multinucleated giant cells 
(large histiocytes) with finely granulated cytoplasm 
of ‘ground glass’ appearance (Fig. 2). The dermis 
was infiltrated throughout its thickness and there 
were no changes seen in the epidermis covering 
the lesion.  An admixture of scattered chronic in-
flammatory cells was seen. 
 Immunohistochemical analysis showed a very 
strong expression of CD68, positive staining for 
S100 protein (Fig. 3) and complete absence of 
CD1a labeling and lagerin (antibodies supplied by 
DAKO: CD68 code N1577, S-100 – N1573, CD1a 
– N1616; antibody supplied by Nocastra: NCL 
– lagerin; staining procedure: EnVision + System-
HRP [DAB]). Electron microscopy did not demon-
strate Birbeck granules. 
 The clinical features, histologic and immuno-
histologic pictures indicated a definitive diagnosis 
of multicentric reticulohistiocytosis.
 Radiologic, biochemical and serologic tests re-
vealed no involvement of internal organs including 
joints and bones, autoimmune disease or malig-
nancy. Rheumatoid factor and antinuclear anti-
bodies were negative. Erythrocyte sedimentation 
rate and cholesterol concentration were within the 
normal range.
 About half a year after the first skin lesions, 
the patient presented again for arthralgia. She felt 
strong pain in the shoulders, elbows, knees and 
hands joints. Medium doses of prednisone (40 mg/
d) were used and complete remission of the joint 
symptoms was achieved in about two weeks. Skin 
lesions showed gradual but moderate improve-
ment. Selected skin lesions were also treated with 
hypodermic injections of steroids, however, with-
out clinical response. The patient has been con-
tinuously followed up.
DISCUSSION
 We describe this case because of the very 
low incidence of multicentric reticulohistiocytosis 
in Polish population. The authors found no report 
from Poland in the English literature. The world-
Figure 1. Clinical presentation with dark-red nod-
ules on the skin of the hands. Small nodules local-
ized over the proximal nail folds are known as a 
‘coral beads’ sign.
Figure 2. Skin biopsy. Abundant infiltration of his-
tiocytes with homogenous copious eosinophilic 
cytoplasm and multinucleated giant cells (large 
histiocytes) with finely granulated cytoplasm of 
‘ground glass’ appearance. The epidermis cov-
ering the lesion remained unchanged. Scattered 
chronic inflammatory cells present in the der-
mis (hematoxylin-eosin staining) (magnification 
X100).
Figure 3. Skin biopsy. Positive staining of histio-
cytes for S-100 protein (antibodies from DAKO: 
S-100 – N1573) (magnification X200).
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wide incidence of the disease is also very low. 
Barrow and Holubar (5) found only 33 patients 
described in medical literature worldwide in the 
1954-1969 period, whereas Luz et al. (1) found 96 
case reports published during the 1977-2001 pe-
riod.
 We consider it worthy of emphasizing the very 
gentle course of the disease during 12 months and 
positive staining for S100 protein in our patient. 
The morphology and localization of skin lesions 
were typical. Arthritis in MR is symmetric and de-
structive (3). Hand joints, knees, wrists and hips 
are usually affected, but all joints can be involved 
(1). In 40%-60% of cases, joint pain occurs before 
skin lesions; however, skin manifestations may 
sometimes precede arthralgia for years. In our pa-
tient, joint symptoms occurred about 6 months af-
ter skin lesions and short therapy with steroids led 
to complete remission of joint pain. We assume 
that, thanks to early treatment, destructive arthritis 
may never get chance to develop.
 In patients suffering from MR many autoim-
mune diseases have been observed. According 
to previous reports, comorbidity of MR and rheu-
matoid arthritis, dermatomyositis, Sjögren’s syn-
drome, scleroderma, primary biliary cirrhosis (4), 
diabetes mellitus, hypothyroidism (5), vasculitis, 
celiac disease, and systemic lupus erythemato-
sus (6) has been reported. The association of MR 
and internal malignancy (about 20%-30%) is also 
widely known. The role of MR as a paraneoplastic 
syndrome is discussed because of the very wide 
spectrum of malignancy types it can be connected 
with. The oncologic process can occur prior to 
or simultaneously with MR. In several cases, the 
treatment of malignancy resulted in complete re-
mission of MR (7).
 Because of the rare incidence of MR and its 
unclear etiopathogenesis, there are no specific 
therapeutic guidelines. The use of prednisone, 
hydroxychloroquine, cyclophosphamide, chloram-
bucil, methotrexate and azathioprine has been 
mentioned in the literature (1). Recent reports on 
treatment using anti-TNF agents like etanercept 
and infliximab in combination with traditional im-
munosuppressants seem to be promising (8,9). 
In our patient, we used only prednisone because 
the course of the disease was mild and the ini-
tial remission of the joint symptoms showed some 
promise.
 In most reports, staining for S100 protein was 
negative (1). Only Miettinen and Fetsch (10) 
observed focal expression in a few cases in a se-
ries of 44 biopsies and Weber et al. (11) revealed 
S100 protein in one case. It is hard to assess 
whether positive staining for this marker can be 
considered decisive for definitive diagnosis. In our 
patient, definitive diagnosis was based on other 
pronounced features of MR.
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